Predictive factors for alirocumab dose increase in patients with heterozygous familial hypercholesterolaemia
File(s)
Author(s)
Vallejo-Vaz, AJ
Roth, EM
Hovingh, GK
Lee, LV
Gervasio, J
Type
Conference Paper
Date Issued
2017-08-12
Date Acceptance
2017-01-20
Citation
Atherosclerosis, 2017, (263), pp.e243-e243
URI
DOI
ISSN
0021-9150
Publisher
Elsevier
Start Page
e243
End Page
e243
Journal / Book Title
Atherosclerosis
Issue
263
Copyright Statement
Copyright © 2017 Published by Elsevier Ltd. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Source
85th European Atherosclerosis Society (EAS) Congress
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Peripheral Vascular Disease
Cardiovascular System & Cardiology
1103 Clinical Sciences
1102 Cardiovascular Medicine And Haematology
Cardiovascular System & Hematology
Publication Status
Published
Start Date
2017-04-23
Finish Date
2017-04-26
Coverage Spatial
Prague, Czech Republic